Your browser doesn't support javascript.
loading
Myocardial inflammation after elective percutaneous coronary intervention.
Merinopoulos, Ioannis; Bhalraam, U; Kasmai, Bahman; Hewson, David; Greenwood, Richard; Eccleshall, Simon C; Smith, James; Tsampasian, Vasiliki; Vassiliou, Vassilios.
Afiliação
  • Merinopoulos I; Norwich Medical School, University of East Anglia, UK; Department of Cardiology, Norfolk and Norwich University Hospital, UK.
  • Bhalraam U; Norwich Medical School, University of East Anglia, UK; Department of Cardiology, Norfolk and Norwich University Hospital, UK.
  • Kasmai B; Norwich Medical School, University of East Anglia, UK.
  • Hewson D; Norwich Medical School, University of East Anglia, UK.
  • Greenwood R; Norwich Medical School, University of East Anglia, UK.
  • Eccleshall SC; Department of Cardiology, Norfolk and Norwich University Hospital, UK.
  • Smith J; Norwich Medical School, University of East Anglia, UK.
  • Tsampasian V; Norwich Medical School, University of East Anglia, UK; Department of Cardiology, Norfolk and Norwich University Hospital, UK.
  • Vassiliou V; Norwich Medical School, University of East Anglia, UK; Department of Cardiology, Norfolk and Norwich University Hospital, UK. Electronic address: v.vassiliou@uea.ac.uk.
Hellenic J Cardiol ; 2024 Jul 01.
Article em En | MEDLINE | ID: mdl-38960369
ABSTRACT

OBJECTIVE:

It is well established that inflammation plays a central role in the sequelae of percutaneous coronary intervention (PCI). Most of the studies to date have focused on the inflammatory reaction affecting the vessel wall after angioplasty. However, there are data to suggest that the main foci of inflammation are in fact in the myocardium beyond the vessel wall. The main aim of our study was to investigate the myocardial inflammation after elective, uncomplicated angioplasty with cardiovascular magnetic resonance (CMR) enhanced by ultrasmall superparamagnetic particles of iron oxide (USPIO) and also blood biomarkers. This is the first study to report such findings after elective angioplasty.

METHODS:

We assessed patients undergoing elective angioplasty for stable angina with USPIO-enhanced CMR two weeks after the procedure and compared the results with those of healthy volunteers who constituted the control group. We excluded patients with previous myocardial infarction, previous PCI, or any significant inflammatory condition. All patients also underwent blood biomarker testing at baseline (pre-PCI), 4 h, and two weeks later.

RESULTS:

A total of five patients and three controls were scanned. There was a small absolute increase, although statistically insignificant, in R2∗ values in the PCI area compared with either remote myocardium from the same patient (PCI area [left anterior descending artery (LAD)] vs remote myocardium [circumflex area] 19.3 ± 10.8 vs 9.2 ± 7.9, p = 0.1) or healthy myocardium from healthy volunteers (PCI area [LAD] vs healthy myocardium [LAD] 19.3 ± 10.8 vs 12.2 ± 4.0, p = 0.2). PTX3 and IL-6 were the only biomarkers that changed significantly from baseline to 4 h and 2 weeks. Both biomarkers peaked at 4 h.

CONCLUSION:

We used USPIO-enhanced CMR for the first time to assess myocardial inflammation after elective, uncomplicated PCI. We have demonstrated a small numerical increase in inflammation, which was not statistically significant. This study opens the way for future studies to use this method as a means to target inflammation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Hellenic J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Hellenic J Cardiol Assunto da revista: CARDIOLOGIA Ano de publicação: 2024 Tipo de documento: Article